News

Patients with prostate cancer may have a lower risk of recurrence if they take multivitamin supplements after diagnosis, new data suggest.
The HHS said it has taken the first step toward implementing most-favored-nation pricing for prescription drugs.
(HealthDay News) — Combined body mass index (BMI)-body surface area (BSA) obesity is associated with an increased risk for post-kidney transplant (KT) adverse outcomes, according to a study published ...
One-year incidence of psychosocial therapy initiation was 12.6 percent, while incidence of medication initiation was 2.8 percent ...
Investigators used the Shiny method, which employs artificial intelligence, to indirectly compare the efficacy of novel systemic therapies for urothelial cancer using phase 3 trial data.
In the benign cohort, initial biopsies showed 37% of patients had ASAP with or without high-grade prostatic intraepithelial neoplasia (HGPIN), while 28% had HGPIN only, and 52% had neither ASAP or ...
The FDA has approved HemiClor (12.5 mg chlorthalidone) tablets for the treatment of hypertension in adults, to lower blood pressure.
The FDA has granted Orphan Drug designation to NS-229 for the treatment of eosinophilic granulomatosis with polyangiitis.
A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on. The US Food and Drug Administration (FDA) ...
The programmed death receptor-1-blocking antibody is approved as a single agent or in combination with chemotherapy. (HealthDay News) — The U.S. Food and Drug Administration has approved the ...
Belimumab increases the complete renal response rate among patients with pure or mixed proliferative class 3 or 4 lupus nephritis (LN) treated with mycophenolate mofetil (MMF). Richard Furie, MD ...
Age-dependent U-shaped trajectories seen for depression and anxiety; symptom levels were significantly higher for survivors ...